Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Last Hour:
Last 24 Hours:

Global Incretin-Based Drugs Market 2016: Industry Segmentation, Parameters and Prospects to 2022

Wednesday, October 12, 2016 4:47
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Latest industry research report on: Global Incretin-Based Drugs Market 2016: Industry Research, Size, Shares, Key Trends, Demand, Growth to 2022

Incretins are gut derived hormones, released after the ingestion of food. Incretins are classified into glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Both the molecules are inactivated by enzyme Dipeptidyl Peptidase-4 (DPP-4). Oral traditional anti-diabetic drugs, often fail to maintain the desired normal level of glucose, especially in the postprandial condition. This has resulted in a strong need for better therapeutics such as incretin based drugs. Incretin not only increases the secretion of insulin by acting on pancreatic beta cells, but also inhibits the release of glucagon by acting on the pancreatic alpha cells. Incretin based drugs namely; Incretin mimetics (GLP-1 agonist) and DPP-4 inhibitors work on the antidiabetic principle of incretin hormone. Incretin based drugs reduce body weight and have better cardiovascular outcomes.

The major drivers of global incretin based drugs market are increasing incidence of diabetes, rising old age population, increasing rate of cardiovascular diseases and obesity, sedentary lifestyle and increasing awareness of diabetes. Furthermore, large number of either undiagnosed or pre-diabetic patients across the globe, could further fuel the market growth. However, high cost of treatment, lack of reimbursement, poor accessibility to drugs especially in developing countries, and some safety concerns associated with incretin based drugs, are likely to restrain the market.

Get Free Sample Report Of Incretin-Based Drugs Market :

The global incretin-based drugs market is segmented on the basis of drug type, formulation, and geography. On the basis of drug type, market is further segmented into Glucagon-like peptide-1 receptor (GLP-1) agonists and Dipeptidyl Peptidase-4 (DPP-4) inhibitors. According to formulation, the market is segmented into oral and injectable drugs. Geographically, the market is segmented across four regions namely North America, Europe, Asia Pacific and LAMEA.

New product launches and approvals are the few strategies adopted by top industry players. Recently GlaxoSmithKline has launched subcutaneous injection of Tanzeum (albiglutide), a GLP-1 agonist for treatment for type 2 diabetes. In March 2015, Takeda Pharmaceutical got Japanese approval for oral tablet Zafatek, a DPP-4 inhibitor. The companies profiled in the report include, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., AstraZeneca plc, Novartis AG, Eli Lilly and Company, Boehringer Ingelheim GmbH, Takeda Pharmaceutical Company Ltd and Sanofi S.A.

Have Any Query? Ask Our Expert @


  • Comprehensive analysis of factors that drive and restrict the growth of the global incretin-based drugs market is provided
  • The market estimations are made in the report by conducting high-end analysis of the key market segments for the period of 2014-2020, which would enable the stakeholders to capitalize on prevailing Market – Opportunities
  • An in-depth analysis of key segments of the market demonstrates the types of drugs and formulations that are currently being used along with the variants that would gain prominence in future
  • SWOT analysis enables to study the internal environment of the leading companies for strategy formulation
  • Region-wise incretin-based drugs market conditions are comprehensively analyzed in the report


The global incretin-based drugs market is segmented below:

  • Global Incretin Based Drugs Market – By Drug Type
  • Glucagon-like peptide-1 receptor (GLP-1) agonists
  • Dipeptidyl Peptidase-4 (DPP-4) inhibitors

Global Incretin Based Drugs Market – By Formulation

  • Oral Drugs
  • Injectable Drugs

Global Incretin Based Drugs Market – By Geography

  • North America
  • Europe
  • Asia-Pacific

About Custom Market Insights:

Market Research supports various market segment programs; provides trusted technical services to the marketing departments. It carries out accurate market share and forecast analysis services for a range of commercial and government customers globally. These are all vital market research support solutions requiring trust and integrity.

Custom Market Insights is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive.

What makes us different from our competitors?

Compared to our competitors, our offerings include, but are not limited to market research services on latest industry trends, customized study at reasonable price, and database bigger than our competitors and provide more relevant results to fit your needs.

Contact Us

Joel John
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442,
United States
Tel: +1-386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No. 1-855-465-4651

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.